文章摘要
杨莉,张禧林.FDA药品安全监管的PPP机制研究及启示[J].中国药事,2017,(12):1381-1385
FDA药品安全监管的PPP机制研究及启示
Research and Inspiration of Public-Private-Partnership Mechanism of FDA Drug Safety Supervision
投稿时间:2017-06-30  
DOI:10.16153/j.1002-7777.2017.12.001
中文关键词: 药品安全  监管管理  PPP机制  运行模式
英文关键词: drug safety  supervision  Public-Private-Partnership mechanism  operation mode
基金项目:辽宁省教育厅2014高等学校科学研究一般项目“辽宁省药品安全监管机制创新研究”(编号W2014119)
作者单位
杨莉 沈阳药科大学工商管理学院, 沈阳 110016 
张禧林 沈阳药科大学工商管理学院, 沈阳 110016 
摘要点击次数: 952
全文下载次数: 611
中文摘要:
      目的:为构建和完善我国药品安全监管公共部门和私人部门的合作伙伴关系,实现资源共享、优势互补、风险共担、利益分享,为公众提供更佳的公共产品和服务的公私合作伙伴机制(public-privatepartnership,PPP)提供建议。方法:运用文献综述法,首先对PPP机制的运行原理以及在药品安全监管中的作用进行理论分析,再对FDA药品安全监管PPP机制的运行模式及实践进行深入研究并得出启示,最后提出完善和构建我国药品安全监管PPP机制的对策与建议。结果: PPP机制在FDA药品安全监管中的应用收到了良好效果,减缓了药品监管部门的资金压力、构建了多种力量参与的药品安全监管网络、推进了医药管理制度改革。结论:我国应该借鉴FDA药品安全监管PPP机制的成功经验,既需要政府部门的有力支持,还要健全法律法规制度,要保证过程的透明和结果公开。
英文摘要:
      Objective: To establish and improve the partnership relation between public sector and private sector of drug safety supervision of China to achieve resource sharing, complementary advantage, risk sharing and beneft sharing and to provide suggestions for better public products and public-private-partnership (PPP) mechanism. Methods: Literature review method was mainly used in this paper. Firstly, operation principle of PPP mechanism and its effects on drug safety supervision were theoretically analyzed. Secondly, the operation mode and practice of PPP mechanism of FDA drug safety supervision were deeply studied and inspiration was obtained. Finally, countermeasures and suggestions to improve and establish the PPP mechanism of drug safety supervision in China were put forward. Resuults: The application of PPP mechanism in FDA drug safety supervision got good effects, the fnancial pressure of drug regulatory authorities was reduced, supervision network of drug safety involving various forces was established, and reform of the medical management system was promoted. Conclusion: We should learn from the successful experiences of the PPP mechanism of FDA drug safety supervision, which needs not only the strong support from the government departments, but also the improvement of laws, regulations and systems to ensure the transparency of the process and the publicity of the results.
查看全文   查看/发表评论  下载PDF阅读器
关闭